
Gerald R. Ewoldt
Examiner (ID: 4358, Phone: (571)272-0843 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644 |
| Total Applications | 1060 |
| Issued Applications | 256 |
| Pending Applications | 142 |
| Abandoned Applications | 661 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4964844
[patent_doc_number] => 20080107664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'Method For Increasing Cd8+ Cytotoxic T Cell Responses And For Treating Multiple Sclerosis'
[patent_app_type] => utility
[patent_app_number] => 10/575831
[patent_app_country] => US
[patent_app_date] => 2004-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6339
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20080107664.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575831
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575831 | Method For Increasing Cd8+ Cytotoxic T Cell Responses And For Treating Multiple Sclerosis | Oct 17, 2004 | Abandoned |
Array
(
[id] => 13165
[patent_doc_number] => 07807377
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-05
[patent_title] => 'Method of isolating antigen-specific T cells employing artificial antigen presenting cells'
[patent_app_type] => utility
[patent_app_number] => 10/960855
[patent_app_country] => US
[patent_app_date] => 2004-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 77
[patent_no_of_words] => 47344
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807377.pdf
[firstpage_image] =>[orig_patent_app_number] => 10960855
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/960855 | Method of isolating antigen-specific T cells employing artificial antigen presenting cells | Oct 5, 2004 | Issued |
Array
(
[id] => 7252531
[patent_doc_number] => 20050142587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Mammalian genes; related reagents and methods'
[patent_app_type] => utility
[patent_app_number] => 10/960450
[patent_app_country] => US
[patent_app_date] => 2004-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25308
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142587.pdf
[firstpage_image] =>[orig_patent_app_number] => 10960450
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/960450 | Mammalian genes; related reagents and methods | Oct 5, 2004 | Abandoned |
Array
(
[id] => 7252157
[patent_doc_number] => 20050074805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Specific markers for diabetes'
[patent_app_type] => utility
[patent_app_number] => 10/952459
[patent_app_country] => US
[patent_app_date] => 2004-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7272
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20050074805.pdf
[firstpage_image] =>[orig_patent_app_number] => 10952459
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/952459 | Specific markers for diabetes | Sep 27, 2004 | Abandoned |
Array
(
[id] => 5807702
[patent_doc_number] => 20060094056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Method of using cytokine assays to diagnose treat, and evaluate inflammatory and autoimmune diseases'
[patent_app_type] => utility
[patent_app_number] => 10/514701
[patent_app_country] => US
[patent_app_date] => 2004-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 48304
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094056.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514701
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514701 | Method of using cytokine assays to diagnose treat, and evaluate inflammatory and autoimmune diseases | Sep 14, 2004 | Abandoned |
Array
(
[id] => 7116241
[patent_doc_number] => 20050069542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Antibodies that specifically bind to GMAD'
[patent_app_type] => utility
[patent_app_number] => 10/935290
[patent_app_country] => US
[patent_app_date] => 2004-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60332
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20050069542.pdf
[firstpage_image] =>[orig_patent_app_number] => 10935290
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/935290 | Antibodies that specifically bind to GMAD | Sep 7, 2004 | Issued |
Array
(
[id] => 5070157
[patent_doc_number] => 20070191259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Inhibition of s6 kinaze activity for the treatment of insulin resistance'
[patent_app_type] => utility
[patent_app_number] => 10/568637
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11654
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191259.pdf
[firstpage_image] =>[orig_patent_app_number] => 10568637
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/568637 | Inhibition of s6 kinaze activity for the treatment of insulin resistance | Aug 19, 2004 | Abandoned |
Array
(
[id] => 5068943
[patent_doc_number] => 20070190044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Compositions and methods for manipulating levels of antigen-specific antibodies in a mammal'
[patent_app_type] => utility
[patent_app_number] => 10/568127
[patent_app_country] => US
[patent_app_date] => 2004-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28330
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20070190044.pdf
[firstpage_image] =>[orig_patent_app_number] => 10568127
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/568127 | Compositions and methods for manipulating levels of antigen-specific antibodies in a mammal | Aug 11, 2004 | Abandoned |
Array
(
[id] => 4812826
[patent_doc_number] => 20080193457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Ra Antigenic Peptides'
[patent_app_type] => utility
[patent_app_number] => 10/567386
[patent_app_country] => US
[patent_app_date] => 2004-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 29736
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20080193457.pdf
[firstpage_image] =>[orig_patent_app_number] => 10567386
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/567386 | Ra Antigenic Peptides | Jul 29, 2004 | Abandoned |
Array
(
[id] => 7152501
[patent_doc_number] => 20050025758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Method and compositions for treatment of insulin-dependant diabetes mellitus'
[patent_app_type] => utility
[patent_app_number] => 10/867149
[patent_app_country] => US
[patent_app_date] => 2004-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7353
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20050025758.pdf
[firstpage_image] =>[orig_patent_app_number] => 10867149
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/867149 | Method and compositions for treatment of insulin-dependant diabetes mellitus | Jun 13, 2004 | Abandoned |
Array
(
[id] => 7181282
[patent_doc_number] => 20040202660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Methods and compositions for treatment of immune dysfunction disorders'
[patent_app_type] => new
[patent_app_number] => 10/470981
[patent_app_country] => US
[patent_app_date] => 2004-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10538
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20040202660.pdf
[firstpage_image] =>[orig_patent_app_number] => 10470981
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/470981 | Methods and compositions for treatment of immune dysfunction disorders | May 19, 2004 | Abandoned |
Array
(
[id] => 9551720
[patent_doc_number] => 08758767
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-24
[patent_title] => 'Antigens targeted by prevalent pathogennic T cells in type 1 diabetes and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/557273
[patent_app_country] => US
[patent_app_date] => 2004-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 22312
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10557273
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/557273 | Antigens targeted by prevalent pathogennic T cells in type 1 diabetes and uses thereof | May 19, 2004 | Issued |
Array
(
[id] => 5799361
[patent_doc_number] => 20060034864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors'
[patent_app_type] => utility
[patent_app_number] => 10/847139
[patent_app_country] => US
[patent_app_date] => 2004-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17074
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20060034864.pdf
[firstpage_image] =>[orig_patent_app_number] => 10847139
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/847139 | Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors | May 16, 2004 | Abandoned |
Array
(
[id] => 7089089
[patent_doc_number] => 20050009202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Methods and compositions for use in the diagnosis and treatment of chronic immune disease'
[patent_app_type] => utility
[patent_app_number] => 10/845777
[patent_app_country] => US
[patent_app_date] => 2004-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17042
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20050009202.pdf
[firstpage_image] =>[orig_patent_app_number] => 10845777
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/845777 | Methods and compositions for use in the diagnosis and treatment of chronic immune disease | May 12, 2004 | Abandoned |
Array
(
[id] => 7060502
[patent_doc_number] => 20050002862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Biological markers for evaluating therapeutic treatment of inflammatory and autoimmune disorders'
[patent_app_type] => utility
[patent_app_number] => 10/845473
[patent_app_country] => US
[patent_app_date] => 2004-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9950
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20050002862.pdf
[firstpage_image] =>[orig_patent_app_number] => 10845473
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/845473 | Biological markers for evaluating therapeutic treatment of inflammatory and autoimmune disorders | May 11, 2004 | Abandoned |
Array
(
[id] => 7033700
[patent_doc_number] => 20050032210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Method of preparing immuno-regulatory dendritic cells and the use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/835591
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 59
[patent_figures_cnt] => 59
[patent_no_of_words] => 18727
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032210.pdf
[firstpage_image] =>[orig_patent_app_number] => 10835591
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/835591 | Method of preparing immuno-regulatory dendritic cells and the use thereof | Apr 29, 2004 | Abandoned |
Array
(
[id] => 7317469
[patent_doc_number] => 20040224304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'ApoCIII and the treatment and diagnosis of diabetes'
[patent_app_type] => new
[patent_app_number] => 10/834525
[patent_app_country] => US
[patent_app_date] => 2004-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7664
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224304.pdf
[firstpage_image] =>[orig_patent_app_number] => 10834525
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/834525 | Methods for identifying compounds for treating type 1 diabetes | Apr 28, 2004 | Issued |
Array
(
[id] => 7263665
[patent_doc_number] => 20040241763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Method for diagnosing multiple sclerosis'
[patent_app_type] => new
[patent_app_number] => 10/835607
[patent_app_country] => US
[patent_app_date] => 2004-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12207
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241763.pdf
[firstpage_image] =>[orig_patent_app_number] => 10835607
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/835607 | Method for diagnosing multiple sclerosis | Apr 27, 2004 | Abandoned |
Array
(
[id] => 6958491
[patent_doc_number] => 20050214861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Human hematopoietic stem and progenitor antigen and methods for its use'
[patent_app_type] => utility
[patent_app_number] => 10/827907
[patent_app_country] => US
[patent_app_date] => 2004-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14445
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214861.pdf
[firstpage_image] =>[orig_patent_app_number] => 10827907
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/827907 | Human hematopoietic stem and progenitor antigen and methods for its use | Apr 18, 2004 | Abandoned |
Array
(
[id] => 7088999
[patent_doc_number] => 20050009112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Methods for identifying Rheb effectors as lead compounds for drug development for diabetes and diseases associated with abnormal cell growth'
[patent_app_type] => utility
[patent_app_number] => 10/796905
[patent_app_country] => US
[patent_app_date] => 2004-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14946
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20050009112.pdf
[firstpage_image] =>[orig_patent_app_number] => 10796905
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/796905 | Methods for identifying Rheb effectors as lead compounds for drug development for diabetes and diseases associated with abnormal cell growth | Mar 7, 2004 | Abandoned |